Navigation Links
Index Ventures Closes Euro 350 Million Early Stage Fund

Ben Holmes Named Partner

LONDON, March 3 /PRNewswire/ -- Index Ventures today announced the closing of a euro 350 million early stage fund, Index Ventures V. The fund is dedicated to early stage and seed investments in the technology, biotechnology and clean technology sectors across Europe, the United States and Israel. It is the fifth early stage fund Index has raised in the past ten years and reinforces the firm's commitment to investing in innovative and disruptive companies, from the very earliest stages. The fund was raised almost entirely from the firm's existing base of limited partners.

"Over the past twelve years, we have been fortunate enough to work with some of the most successful entrepreneurs in the world who have started game-changing companies such as Betfair, Skype, MySQL and GenMab," said partner Bernard Dalle. "There are certainly challenges facing many industries right now but, thanks to the ongoing commitment of our limited partners, we can continue to focus on our core strength, that of finding and supporting ambitious, dedicated entrepreneurs."

Operating from offices in Geneva, London and Jersey, Index invests in companies across multiple geographies. Investments made during the last twelve months include: Criteo (France), DimDim (India), Lehigh Technologies (US), MyHeritage (Israel), NormOxys (France), OpTier (Israel), Playfish (UK), RightScale (US), and WooMe (UK/US).

Francesco De Rubertis, Index partner, added, "On the biotech side, Index is focused on finding the best companies with the strongest pipelines. We are equally interested in very early stage ventures and more mature companies with established proof-of-concept. In terms of therapeutic areas, our priorities are oncology, CNS, immunology and inflammation. We continue to see tremendous innovation and development within these areas, driven in part by the ever growing pharmaceutical pipeline deficit."

Index also announced today that Ben Holmes, a London-based member of the technology team since 2002, has been named a partner of the firm. Ben focuses on investments in consumer and internet infrastructure companies and currently sits on a number of boards including Mind Candy, Netlog, Playfish, Rebtel and Stardoll.

"Since joining our London office in 2002, Ben has played a key role in sourcing and supporting investments we have made in internet and software sectors," said Danny Rimer, partner at Index Ventures. "We are excited to announce his promotion and we look forward to his ongoing contributions to the firm and our portfolio companies."

In addition, Tony Zappala and Roman Fleck, both based in the firm's Geneva office, have been promoted to principals in the IT and biotech teams respectively.

About Index

Index Ventures is a leading venture capital firm active in venture investing since 1996. For more information, please visit

SOURCE Index Ventures
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Names New Senior Science Officer; Added to S&P Index
2. NASDAQ OMX AeA Illinois Tech Index Outperforms Market
3. Micromet Added to NASDAQ Biotechnology Index
4. Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices
5. Chindex International, Inc. Announces Appearances at Upcoming Investor Conferences
6. Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year
7. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
8. Advanced Life Sciences Added to Russell Microcap Index
9. Bioheart, Inc., Added to Russell Microcap Index
10. Pharmasset Joins Russell 3000 Index
11. Caliper Life Sciences Added to Russell 3000(R) Index
Post Your Comments:
(Date:11/30/2015)... JACKSONVILLE, Florida , November 30, 2015 ... company specializing in the development of innovative peptide and ... & metastatic disease, today announced it will be presenting ... Event on December 1, 2015 at 2.30 PM PT. ... member and Strategic Advisor will be giving the presentation ...
(Date:11/30/2015)... Md. , Nov. 30, 2015  Northwest Biotherapeutics ... company developing DCVax® personalized immune therapies for solid tumor ... adding an additional independent director, and the Company welcomes ... of allegations in a recent anonymous internet report on ... both initiatives. Linda Powers stated, "We ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... that includes over 2,000 technical presentations offered in symposia, oral sessions, workshops, awards, ... spectroscopy, covers a wide range of applications such as, but not limited to, ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
Breaking Biology Technology:
(Date:10/27/2015)... BERLIN, Germany , October 27, 2015 ... 2015. SMI,s Automated Semantic Gaze Mapping technology (ASGM) automatically ... SMI,s Eye Tracking Glasses , so that ... Suite BeGaze. --> Munich, Germany ... technology (ASGM) automatically maps data from mobile eye tracking ...
(Date:10/26/2015)... LAS VEGAS , Oct. 26, 2015 /PRNewswire/ ... innovator in modern authentication and a founding member of ... of its latest version of the Nok Nok™ S3 ... use standards-based authentication that supports existing and emerging methods ... is ideal for organizations deploying customer-facing applications that require ...
(Date:10/23/2015)... and GOLETA, California , October 23, ... BIOPAC and SensoMotoric Instruments (SMI) announce a mobile plug ... data captured during interactive real-world tasks SensoMotoric ... integration of their established wearable solutions for eye tracking ... gaze behavior captured with SMI Eye Tracking Glasses ...
Breaking Biology News(10 mins):